MedPath

BiodEgradable Soaked Amiodarone PaTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery

Phase 3
Not yet recruiting
Conditions
Atrial Fibrillation (AF)
Interventions
Other: saline solution patch
Registration Number
NCT06722196
Lead Sponsor
Jilin Heart Hospital
Brief Summary

The primary objective of the present prospective, randomized, double blind, controlled study is to assess whether the application of 2 oxidized regenerated cellulose (SurgicelTM FibrillarTM) patches soaked with amiodarone hydrochloride over the anterior wall of the left atrium and the lateral wall of the right atrium results in a reduction in the incidence of POAF

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • All patients who are candidates for elective cardiac surgery trough complete sternotomy with indications of coronary artery disease (both off-pump and on-pump), aortic valve disease, mitral valve disease, tricuspid valve disease, and ascending aorta disease, whether as an isolated pathology or in combination
Exclusion Criteria
  • patients with a clinical history of atrial or ventricular arrhythmia of any nature and duration, patients undergoing reoperation, patients with emergency surgical indications due to acute myocardial infarction or cardiogenic shock, patients with thyroid disfunction, patients with HOCM and those with pacemakers or ICDs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimentaltopical amiodaronepatients will receive 2 patches soaked in cordarone hydrochloride (150 mg/3 ml each)
Shamsaline solution patchpatients will receive 2 patches soaked in saline solution (3 ml each)
Primary Outcome Measures
NameTimeMethod
postoperative atrial fibrillation versus controlwithin 5 days after surgery

incidence of in-hospital atrial fibrillation

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath